Receiving a low AMH result is one of the more unsettling moments in a fertility workup. Anti-Mullerian hormone is widely used as a marker of ovarian reserve, and a low reading can feel like a door closing. But what does a low AMH score actually mean for your chances of pregnancy, and what options exist for women in this situation?
The honest answer is that AMH is a useful but imperfect predictor. It tells you how many eggs are likely remaining, but it says relatively little about the quality of those eggs. For many women with low AMH, the right clinical approach makes a significant difference. A low AMH fertility specialist like those at Hanabusa IVF in San Diego works specifically with this patient population, using protocols designed around the individual biology of women with diminished ovarian reserve rather than a standard high-dose IVF model that tends to underserve them.
This guide explains what AMH measures, what different AMH levels mean, how low AMH affects fertility treatment, and what your options are if you have received a low result.
What Is AMH and What Does It Measure?
AMH, or anti-Mullerian hormone, is produced by granulosa cells in ovarian follicles. Specifically, it is secreted by the small, resting follicles known as antral follicles, which represent the pool of eggs that could potentially be recruited for ovulation in future cycles. Because AMH is secreted consistently across the menstrual cycle, it can be measured at any time, making it a convenient and reliable marker for ovarian reserve assessment.
Unlike FSH, which fluctuates across the cycle, AMH remains relatively stable from day to day and month to month. This consistency is part of what makes it such a useful tool in fertility evaluation. However, AMH reflects quantity, not quality. A woman with a low AMH but good egg quality may have a better prognosis than her numbers alone suggest.
What AMH Levels Mean
AMH values are reported in nanograms per milliliter (ng/mL) or picomoles per liter (pmol/L). The reference ranges vary somewhat between laboratories, but general interpretive categories used by many fertility specialists are as follows.
Values above 1.0 ng/mL are typically considered normal for a woman's reproductive age, though the precise threshold for normal depends on age. AMH naturally declines over time, so a reading that would be low for a 25-year-old may be expected for a 40-year-old.
Values between 0.5 and 1.0 ng/mL suggest borderline or mildly diminished ovarian reserve and warrant close monitoring and individualized treatment planning.
Values below 0.5 ng/mL indicate significantly diminished ovarian reserve. At this level, conventional IVF stimulation often produces a limited response, and alternative protocols may be more appropriate.
Values near or below 0.1 ng/mL indicate severely diminished reserve. For some women at this level, donor egg IVF may offer the most realistic path to pregnancy, though some clinics report success with Mini IVF even at very low AMH.
How Low AMH Affects Fertility Treatment
Low AMH primarily affects the approach to IVF stimulation. The standard IVF model uses high doses of injectable gonadotropins to stimulate the ovaries to produce many eggs at once. For women with normal or high ovarian reserve, this produces a large cohort of eggs to work with. For women with low AMH, the same high doses often produce only marginally more eggs than a lower-dose approach, while introducing significantly more side effects and cost.
The key insight from research and clinical experience is that for DOR patients, pushing harder does not reliably produce proportionally better results. A more targeted, lower-dose approach that nurtures the few available eggs often leads to better egg quality, more viable embryos, and comparable or better outcomes per cycle than aggressive stimulation in this population.
Mini IVF as a Strategy for Low AMH
Mini IVF, also called minimal stimulation IVF, uses oral medications such as clomiphene citrate with low-dose injectables, or injectables alone at much lower doses than conventional protocols. The goal is to recruit two to five high-quality eggs rather than attempting to override the ovary's natural limitations.
The advantages for low AMH patients are significant. Lower medication doses mean lower costs per cycle. Reduced stimulation means less physical discomfort and a dramatically lower risk of ovarian hyperstimulation syndrome. And because the approach works with the ovary's natural biology rather than against it, the eggs retrieved may be of higher quality relative to what a maximally stimulated cycle would produce in the same patient.
Mini IVF also allows for more frequent cycling. Because the physical recovery is less demanding, some patients can attempt a retrieval cycle more often than would be possible after conventional high-stimulation protocols. For women with low AMH who may need multiple retrievals to bank enough embryos, this can shorten the overall timeline to transfer.
Natural Cycle IVF and Modified Natural Cycle
For women with very low AMH who do not respond meaningfully to any stimulation protocol, natural cycle IVF involves retrieving the single egg the body selects naturally that month without any fertility medications. Success rates per cycle are lower than stimulated approaches, but for a subset of patients this is the only viable path to using their own eggs.
Modified natural cycle IVF adds minimal medication only in the final days before retrieval to prevent premature ovulation and optimize the timing and quality of the single egg. This middle path suits patients who produce one or two follicles naturally but would benefit from protecting that follicle through the retrieval window.
When Donor Eggs Become the Right Path
Not every woman with low AMH will achieve pregnancy with her own eggs, and it is important for anyone pursuing fertility treatment to understand the full range of options without viewing donor eggs as a failure. Using a donated egg from a younger, screened donor allows a woman to carry a pregnancy and experience childbirth while using genetic material from a donor whose reserve is not compromised.
For many women, the experience of carrying the pregnancy and delivering the child is the most important aspect of parenthood. Donor egg IVF makes this possible even for women whose ovarian reserve is severely depleted, and success rates with donor eggs are generally high because they remove the age and reserve variables that limit natural egg outcomes.
Lifestyle Factors and Low AMH
While no lifestyle intervention can restore depleted ovarian reserve, some evidence suggests that specific factors may support egg quality and reduce further decline.
Coenzyme Q10 (CoQ10) is an antioxidant that plays a role in cellular energy production and has been studied for its potential to support mitochondrial function in eggs. While evidence remains preliminary, many fertility specialists recommend CoQ10 supplementation for DOR patients as a low-risk supportive measure.
Minimizing alcohol consumption, avoiding smoking, managing chronic stress, and maintaining a healthy weight are all supportive steps. Oxidative stress is known to be damaging to egg quality, and a lifestyle that reduces oxidative load is broadly sensible for any woman in active fertility treatment.
Vitamin D deficiency has also been associated with poorer IVF outcomes in some studies. Testing and supplementing vitamin D when deficient is a simple intervention with a reasonable evidence base.
The Importance of Individualized Care
Low AMH is not a diagnosis that fits neatly into a single treatment algorithm. The right path forward depends on a woman's age, specific AMH and AFC values, prior treatment history, reproductive goals, and personal circumstances. What works well for a 32-year-old with a mildly low AMH may be entirely different from the best approach for a 39-year-old with severely depleted reserve.
This is why choosing a clinic that takes a genuinely individualized approach matters so much. Clinics that apply a single standard protocol to all patients, regardless of ovarian reserve, are unlikely to serve DOR patients optimally.
Conclusion
A low AMH result is not a verdict. It is information, and information used well by an experienced clinical team can make all the difference. The key is finding specialists who understand the nuances of treating patients with diminished ovarian reserve and who have the protocols and experience to match the treatment to the patient.
Women facing low AMH diagnoses who are exploring their options can connect with the team at Hanabusa IVF in San Diego for a personalized consultation. The clinic specializes in Mini IVF and low-stimulation fertility care for patients with diminished ovarian reserve, low AMH, and prior IVF failure, and offers individualized treatment planning based on each patient's unique profile.